Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors. Quantitative proteomics using iTRAQ was then performed to ascertain protein abundance differences between ADSCs, beta-mercaptoethanol treated ADSCs and a glioblastoma cell line. Pharmacological treatments of presbyopia: a review of modern prednisone...